In "early" gastric cancer the depth of invasion by the primary tumour is confined to the submucosa of the stomach. Out 
Introduction
Gastric cancer is defined as "early" when the depth of invasion by the tumour is histologically limited to the submucosal layer of the stomach.' The depth of penetration by the primary lesion is closely related to survival,1 and in Japan the five-year survival rate of patients with early gastric cancer was reportedly 90 4%. 4 
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makes analysis of survival difficult. Evans et a14 showed that the microscopical features of 14 early gastric cancers in Britain were similar to those seen in Japan but were unable to assess survival because of small numbers and inadequate follow-up. We have therefore identified the early gastric cancers among all gastric cancers notified to the Birmingham Cancer Registry during 1960-9 and report here the natural history of the lesion.
Subjects and methods
We reviewed all patients notified to the Birmingham Cancer Registry during 1960-9 with histologically proved adenocarcinoma of the stomach. Histological reports were analysed and the depth of invasion by the primary lesions assessed. Though lymph-node metastasis may occur in early gastric cancer,5 we consider here only patients with histologically normal nodes in whom the depth of penetration was clearly documented. In several patients with normal lymph nodes the depth of invasion was not documented, and we reviewed the histological sections in these cases to permit accurate identification of early gastric cancers in the period under review.
Microscopically all the early gastric cancers were confined to the mucosa and submucosa and did not penetrate the muscularis propria. Macroscopically they were classified by the method of Murakami6 as (I) protruded, (II) superficial, or (III) excavated. It was not possible in a retrospective review to subdivide these groups further.
Detailed analysis of all these patients was made from cancer registry information. Survival rates described as "crude" are merely the proportion of patients who were still alive at the time of assessment. These crude rates were "age adjusted"7 for overall survival rates. The object was to relate mortality from cancer to the general mortality at the same age, so avoiding the use of inappropriate comparisons that might be grossly disturbed by differences in the ages of patients treated.
Results
During the 10 years the registry had been notified of 13 228 cases of gastric adenocarcinoma, of which 3523 (26 60,o) were treated by resection. Of these cases, we identified 90 (070o of the whole series) as early gastric cancer. The mean age at presentation of the 90 patients was 62 3 years, and the condition was most common in the fifth and sixth decades (table I). Fifty-nine of the patients were men and 31 women.
Of the 90 lesions, 60 were in the pyloric antrum, 10 in the body of the stomach, two at the junction of the body and antrum, and three at the cardia; in 15 cases The method of diagnosis was evaluated in 54 patients. In 40 cases barium studies had been performed, 37 of which had shown abnormalities and three nothing abnormal. Fourteen patients were diagnosed at laparotomy. Fibreoptic endoscopy had been used in only one of these patients.
Fifty patients had shown evidence of gastric disease preoperatively, though in only 23 was carcinoma suspected (table III) . In 29 cases we could not establish the preoperative diagnosis. At operation a further Many features in gastric carcinoma apply to early gastric cancers. They were more common in men than women, and the highest incidence occurred between the ages of 55 and 65. Survival, however, was significantly better. The crude five-year survival7 rate of all patients from the first six years was 3-70/% (age-adjusted rate 4-7%/ ), and the crude five-year survival after radical treatment was 14 6%' (age-adjusted rate 17-4%). The crude five-year survival of the 90 patients with early gastric cancer was 57 8%,' (age-adjusted rate 7044%). The prognosis in patients under 70 was better than in the older age group, and established prognostic factors such as sex7 and length of preoperative history9 pertained equally to early gastric cancer. Although early gastric cancer is associated with increased survival at five and 10 years, the true effect of increasing the detection of early gastric cancer cannot be fully evaluated until the effect on yearly gastric cancer mortality rates is known.
Early gastric cancers present with symptoms referable to the gastrointestinal tract (table II) and may be diagnosed preoperatively. In advanced gastric carcinoma 78% of patients have lost weight on admission to hospital'0; however, this was not a constant feature of the early lesions. Most patients with early lesions had had gastric disease diagnosed preoperatively (table III) ; undoubtedly, with the advent of fibreoptic endoscopy and double-contrast radiology many more would have had histologically proved gastric cancers preoperatively.
All 90 patients were treated surgically. As only 32 had cancer diagnosed either preoperatively or at the time of operation, probably resection did not always include removal of appropriate lymph nodes.1' Desmond et al-'2 showed that revisional surgery for histological gastric carcinomas of macroscopic benign disease was associated with a five-year survival rate of 56%; in patients not subjected to further surgery, however, the five-year survival was 23%. In our series most patients had partial gastrectomies, and the results were good when compared with other results for gastric cancer in Britain. The high postoperative mortality among the few patients having total gastrectomies corresponded with the 21 %O postoperative mortality reported by Longmire." Hence radical subtotal gastrectomy with excision of appropriate primary, secondary, and tertiary lymph nodes should probably be recommended." Follow-up to assess the residual stomach for evidence of malignancy should include regular endoscopy during the first five years, since most cancerrelated deaths occur during this time ( figure, table IV) . The Japanese results with the management of gastric cancer differ appreciably from those seen elsewhere,'4 but this may be a different lesion. Evans et a14 failed to identify any macroscopic or microscopical differences in early gastric cancer. Our retrospective study permitted identification and assessment of this group, establishing that an early lesion is the most important prognostic factor in gastric cancer. Direct comparisons with the Japanese results can be made only when similar methods of diagnosis, resection, and histological staging are used.
The increase in the number of patients seen with early gastric cancer in Japan was associated with the introduction of mass screening of asymptomatic populations. The pick-up rate of screening was 0-37%15 in a country with a gastric cancer mortality rate of 68 per 100 000 population. In the West Midlands the mortality rate was 23 per 100 000,16 and mass screening would be difficult to justify on economic grounds. The detection of early lesions may be increased with more clinical awareness and -investigation of dyspeptic patients, preferably before weight loss begins. Screening programmes should be considered for dyspeptic patients over the age of 40 living in high-risk environments, such as Stoke-on-Trent9 and the coalmining areas of Wales.'7
The incidence of gastric cancer is decreasing in America,18 Japan,'9 and the West Midlands (J Waterhouse, personal communication, 1980). Even so, it continues to rank second as a contributory cause of death from cancer in the West Midlands (J Waterhouse). As in Japan, advanced gastric cancer will remain the most frequently encountered lesion, and efforts should be made to improve treatment. Chemotherapy and radiotherapy are being evaluated under the guidance of the British stomach cancer group, and radical excision of the primary growth with removal of appropriate primary, secondary, and tertiary draining lymph nodes must be undertaken to provide exact staging and clearance of the lesion. In combination with efforts to diagnose gastric cancer at an early stage this may produce benefits in the treatment of the condition, which has shown no noticeable improvement over the past 30 years.
